NO20083695L - Meridamycin analoger for behandlingen av neurodegenererende sykdommer - Google Patents
Meridamycin analoger for behandlingen av neurodegenererende sykdommerInfo
- Publication number
- NO20083695L NO20083695L NO20083695A NO20083695A NO20083695L NO 20083695 L NO20083695 L NO 20083695L NO 20083695 A NO20083695 A NO 20083695A NO 20083695 A NO20083695 A NO 20083695A NO 20083695 L NO20083695 L NO 20083695L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- neurodegenerative diseases
- meridamycin
- analogues
- meridamycin analogues
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Det beskrives en forbindelse med strukturen vist nedenfor. Denne forbindelse og dens anvendelse for fremstilling av medikamenter anvendelige ved behandlingen av neurodegenerative forstyrrelser, er beskrevet.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77994006P | 2006-03-07 | 2006-03-07 | |
PCT/US2007/005645 WO2007103347A1 (en) | 2006-03-07 | 2007-03-05 | Meridamycin analogues for the treatment of neurodegenerative disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20083695L true NO20083695L (no) | 2008-10-03 |
Family
ID=38289934
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20083695A NO20083695L (no) | 2006-03-07 | 2008-08-27 | Meridamycin analoger for behandlingen av neurodegenererende sykdommer |
Country Status (19)
Country | Link |
---|---|
US (1) | US7745457B2 (no) |
EP (1) | EP1991551A1 (no) |
JP (1) | JP2009529049A (no) |
KR (1) | KR20080099317A (no) |
CN (1) | CN101426796A (no) |
AR (1) | AR059738A1 (no) |
AU (1) | AU2007223962A1 (no) |
BR (1) | BRPI0708611A2 (no) |
CA (1) | CA2643350A1 (no) |
CR (1) | CR10272A (no) |
EC (1) | ECSP088718A (no) |
IL (1) | IL193414A0 (no) |
MX (1) | MX2008011312A (no) |
NO (1) | NO20083695L (no) |
PE (1) | PE20081550A1 (no) |
RU (1) | RU2008132779A (no) |
TW (1) | TW200804400A (no) |
WO (1) | WO2007103347A1 (no) |
ZA (1) | ZA200807678B (no) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7276498B2 (en) * | 2004-12-20 | 2007-10-02 | Wyeth | Rapamycin analogues and uses thereof in the treatment of neurological disorders |
BRPI0519593A2 (pt) * | 2004-12-20 | 2009-02-25 | Wyeth Corp | composto, mÉtodos de tratar distérbios neurodegenerativos e complicaÇÕes devido a derrame ou trauma na cabeÇa, e de preparar um composto, e, uso de um composto |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9302016D0 (en) | 1993-02-02 | 1993-03-17 | Sandoz Ltd | Compounds |
GB9318144D0 (en) | 1993-09-01 | 1993-10-20 | Sandoz Ltd | Organic compounds |
EP0729471A1 (en) | 1993-11-19 | 1996-09-04 | Abbott Laboratories | Semisynthetic analogs of rapamycin (macrolides) being immunomodulators |
AU2005219822A1 (en) | 2004-03-02 | 2005-09-15 | Wyeth | Macrolides and methods for producing same |
EP1720548A1 (en) * | 2004-03-02 | 2006-11-15 | Wyeth | Non-immunosuppressive immunophilin ligands as neuroprotective and/or neuroregenerative agents |
CA2567043A1 (en) * | 2004-06-03 | 2005-12-22 | Wyeth | Biosynthetic gene cluster for the production of a complex polyketide |
WO2006053313A2 (en) * | 2004-11-12 | 2006-05-18 | Wyeth | Elaiophylin biosynthetic gene cluster |
US7276498B2 (en) | 2004-12-20 | 2007-10-02 | Wyeth | Rapamycin analogues and uses thereof in the treatment of neurological disorders |
BRPI0519593A2 (pt) | 2004-12-20 | 2009-02-25 | Wyeth Corp | composto, mÉtodos de tratar distérbios neurodegenerativos e complicaÇÕes devido a derrame ou trauma na cabeÇa, e de preparar um composto, e, uso de um composto |
-
2007
- 2007-03-05 RU RU2008132779/04A patent/RU2008132779A/ru not_active Application Discontinuation
- 2007-03-05 JP JP2008558346A patent/JP2009529049A/ja active Pending
- 2007-03-05 KR KR1020087021820A patent/KR20080099317A/ko not_active Application Discontinuation
- 2007-03-05 CA CA002643350A patent/CA2643350A1/en not_active Abandoned
- 2007-03-05 BR BRPI0708611-3A patent/BRPI0708611A2/pt not_active Application Discontinuation
- 2007-03-05 AR ARP070100899A patent/AR059738A1/es unknown
- 2007-03-05 CN CNA2007800078343A patent/CN101426796A/zh active Pending
- 2007-03-05 EP EP07752355A patent/EP1991551A1/en not_active Withdrawn
- 2007-03-05 MX MX2008011312A patent/MX2008011312A/es not_active Application Discontinuation
- 2007-03-05 US US11/713,972 patent/US7745457B2/en not_active Expired - Fee Related
- 2007-03-05 AU AU2007223962A patent/AU2007223962A1/en not_active Abandoned
- 2007-03-05 WO PCT/US2007/005645 patent/WO2007103347A1/en active Application Filing
- 2007-03-05 TW TW096107510A patent/TW200804400A/zh unknown
- 2007-03-09 PE PE2007000263A patent/PE20081550A1/es not_active Application Discontinuation
-
2008
- 2008-08-12 IL IL193414A patent/IL193414A0/en unknown
- 2008-08-27 NO NO20083695A patent/NO20083695L/no not_active Application Discontinuation
- 2008-09-05 CR CR10272A patent/CR10272A/es not_active Application Discontinuation
- 2008-09-05 ZA ZA200807678A patent/ZA200807678B/xx unknown
- 2008-09-05 EC EC2008008718A patent/ECSP088718A/es unknown
Also Published As
Publication number | Publication date |
---|---|
AR059738A1 (es) | 2008-04-23 |
ZA200807678B (en) | 2009-08-26 |
ECSP088718A (es) | 2008-10-31 |
US20070213525A1 (en) | 2007-09-13 |
TW200804400A (en) | 2008-01-16 |
MX2008011312A (es) | 2008-09-12 |
BRPI0708611A2 (pt) | 2011-06-07 |
RU2008132779A (ru) | 2010-04-20 |
CR10272A (es) | 2008-10-03 |
EP1991551A1 (en) | 2008-11-19 |
JP2009529049A (ja) | 2009-08-13 |
AU2007223962A1 (en) | 2007-09-13 |
WO2007103347A1 (en) | 2007-09-13 |
IL193414A0 (en) | 2009-05-04 |
KR20080099317A (ko) | 2008-11-12 |
PE20081550A1 (es) | 2008-12-31 |
CA2643350A1 (en) | 2007-09-13 |
US7745457B2 (en) | 2010-06-29 |
CN101426796A (zh) | 2009-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL260117A (en) | Use of placental cells to treat diseases, syndromes or conditions of the lungs | |
CY2016015I2 (el) | Αζετιδινες ως αναστολεις μεκ για τη θεραπευτικη αγωγη πολλαπλασιαστικων ασθενειων | |
NO20081527L (no) | Anvendelse av flibanserin for behandling av pre-menopausal seksuell lyst forstyrrelser | |
EP1937633B8 (en) | Biphenyloxyacetic acid derivatives for the treatment of respiratory disease | |
LTC1781298I2 (lt) | Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui | |
WO2007038459A3 (en) | Carboxyamine compounds and their use in the treatment of hdac dependent diseases | |
UA115320C2 (uk) | Інгібітори кінази | |
WO2009064388A3 (en) | Inhibitors of human methionine aminopeptidase 1 and methods of treating disorders | |
WO2007087468A3 (en) | Adiponectin for treatment of various disorders | |
CL2007002641A1 (es) | Compuestos derivados de pirimidinas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de trastornos alergicos, autoinmunes, enfermedades inflamatorias. | |
CL2007003520A1 (es) | Compuestos derivados de heterociclos sustituidos con morfolina, inhibidores de la actividad pi3 quinasa; composicion farmaceutica que comprende a dichos compuestos; kit farmaceutico; y su uso para el tratamiento profilactico o terapeutico del cancer. | |
EA201100335A8 (ru) | Производные пурина для применения при лечении связанных с fab заболеваний | |
NO20065535L (no) | Behandling av respiratorisk sykdom | |
CY1112320T1 (el) | Τιτλοδοτηση της ταπενταδολης | |
DK1940409T3 (da) | Nye lægemiddelkombinationer til behandling af åndedrætssygdomme | |
DK2056842T3 (da) | Modificeret galactosylceramid til behandling af cancerøse sygdomme | |
TWI369988B (en) | New pharmaceutically active compounds for the treatment of respiratory diseases | |
EA200702336A1 (ru) | ПРИМЕНЕНИЕ 24-норУДХК | |
AU2012308243A8 (en) | Use of indolyl and indolinyl hydroxamates for treating heart failure of neuronal injury | |
NO20083695L (no) | Meridamycin analoger for behandlingen av neurodegenererende sykdommer | |
TWI365753B (en) | Use of adamantyl methoxydiphenyl propenoic acid for the treatment of dermatological diseases | |
EA200900923A1 (ru) | Применение нейропротективных соединений в получении лекарственных средств, предназначенных для лечения нейродегенеративных заболеваний | |
WO2008037937A3 (fr) | Utilisation de composes de la famille des milbemycines pour le traitement de desordres dermatologiques chez l'homme | |
EP1864671A4 (en) | USE OF HYDROCHLORIC ACID FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF HYPERTENSION | |
WO2007107696A3 (en) | Pharmaceutically acceptable salts and polymorphic forms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |